Akoya Biosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akoya biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akoya Biosciences Inc Today - Breaking & Trending Today

Brian Mckelligon Sells 7,500 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $2.08, for a total value of $15,600.00. Following the completion of the sale, the chief executive officer now owns 224,733 shares of […] ....

United States , Akoya Biosciences , Brian Mckelligon , Asia Pacific , Peddock Capital Advisors , Nisa Investment Advisors , Schonfeld Strategic Advisors , Polar Capital Holdings Plc , Kent Lake Capital , Jpmorgan Chase Co , Securities Exchange Commission , Akoya Biosciences Inc , Morgan Stanley , Canaccord Genuity Group , Get Free Report , Exchange Commission , Genuity Group , Strategic Advisors , Lake Capital , Capital Holdings Plc , Investment Advisors , Capital Advisors , North America , Middle East , Akoya Biosciences Daily ,

Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian Mckelligon Sells 7,500 Shares

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $2.08, for a total value of $15,600.00. Following the transaction, the chief executive officer now directly owns 224,733 shares […] ....

United States , Brian Mckelligon , Asia Pacific , Akoya Biosciences , Morgan Stanley , Polar Capital Holdings Plc , Akoya Biosciences Company Profile , Tower Research Capital , Schonfeld Strategic Advisors , Canaccord Genuity Group , Akoya Biosciences Inc , Jpmorgan Chase Co , Vanguard Group Inc , Nisa Investment Advisors , Get Free Report , Investment Advisors , Strategic Advisors , Research Capital , Capital Holdings Plc , Genuity Group , North America , Middle East , Akoya Biosciences Daily ,

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 11.5% in May

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,160,000 shares, an increase of 11.5% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 276,300 shares, the days-to-cover […] ....

United States , Asia Pacific , Akoya Biosciences , Brian Mckelligon , Jpmorgan Chase Co , Parkman Healthcare Partners , Asset Management Inc , Silvercrest Asset Management Group , Kent Lake Capital , Akoya Biosciences Inc , Akoya Biosciences Company Profile , Peddock Capital Advisors , Canaccord Genuity Group , Get Free Report , Lake Capital , Asset Management Group , Capital Advisors , Healthcare Partners , Management Inc , Genuity Group , North America , Middle East , Akoya Biosciences Daily ,

Akoya Biosciences, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.28) Per Share (NASDAQ:AKYA)

Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Capital One Financial lowered their Q2 2024 EPS estimates for shares of Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will earn ($0.28) per share for the quarter, down from their prior estimate […] ....

United States , Akoya Biosciences , Akoya Bioscience , Asia Pacific , Brian Mckelligon , Jpmorgan Chase Co , Akoya Biosciences Inc , Asset Management Inc , Silvercrest Asset Management Group , Tower Research Capital , Canaccord Genuity Group , Vanguard Group Inc , Securities Exchange Commission , Parkman Healthcare Partners , Free Report , Capital One Financial , One Financial , Get Free Report , Genuity Group , Biosciences Stock Down , Asset Management Group , Healthcare Partners , Research Capital , Management Inc , Exchange Commission , North America ,

Akoya Biosciences, Inc. (NASDAQ:AKYA) to Post Q2 2024 Earnings of ($0.28) Per Share, Capital One Financial Forecasts

Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Stock analysts at Capital One Financial dropped their Q2 2024 earnings per share estimates for Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will post earnings of ($0.28) per share for the quarter, […] ....

United States , Brian Mckelligon , Akoya Bioscience , Asia Pacific , Akoya Biosciences , Asset Management Inc , Canaccord Genuity Group , Nisa Investment Advisors , York Mellon Corp , Akoya Biosciences Inc , Tower Research Capital , Akoya Biosciences Company Profile , Jpmorgan Chase Co , Schonfeld Strategic Advisors , Free Report , Capital One Financial , One Financial , Get Free Report , Biosciences Stock Down , Investment Advisors , Research Capital , Management Inc , Strategic Advisors , New York Mellon Corp , North America , Middle East ,